Gene therapy

Regeneron Makes History: FDA Approves Otarmeni, the First Gene Therapy for Rare Genetic Hearing Loss NEW YORK — In a landmark victory …

The medical community is witnessing a paradigm shift in the treatment of congenital deafness, moving from the lifelong reliance on prosthetic hardware …

Alzheimer’s Research: Gene Therapy and Cellular Approaches Offer New Hope The landscape of Alzheimer’s disease research is undergoing a significant shift, moving …

In a landmark decision offering hope to families facing a devastatingly rare condition, the Food and Drug Administration (FDA) has granted approval …

Nearly 7,000 rare diseases affect over 300 million people worldwide, and the price tag for treating just one – Spinal Muscular Atrophy …

<p>Nearly 80% of rare diseases are genetic in origin, impacting an estimated 300 million people worldwide. But for families like Ginny’s in …

Beyond Insulin: How Gene-Modified Cells Could Eradicate Type 1 Diabetes Over 1.2 million Americans live with Type 1 diabetes, a chronic autoimmune …

FDA Chief Makary Defends Agency’s Rigorous Rare Disease Drug Review Process WASHINGTON – Food and Drug Administration Commissioner Robert Califf’s successor, Marty …

Breakthrough in Leukemia Treatment: Base-Edited CAR T-Cells Achieve Remission In a landmark advancement for cancer therapy, researchers have demonstrated the effectiveness of …

Pancreatic cancer, notoriously one of the deadliest forms of the disease, has historically defied effective treatment. But a confluence of recent clinical …